Vincerx Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Applied Therapeutics (APLT) and Vincerx Pharma Inc (VINC)
Vincerx Pharma Analyst Ratings
Buy Rating Affirmed for Vincerx Pharma Ahead of AACR Presentation: Promising Developments in Oncology Drug Pipeline
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Vincerx Pharma Inc (VINC) and Pharvaris (PHVS)
Vincerx Pharma Analyst Ratings
Vincerx Pharma Inc (VINC) Gets a Buy From SVB Securities
Chardan Trims Price Target on Vincerx Pharma to $3 From $4, Keeps Buy Rating
Vincerx Pharma Analyst Ratings
Chardan Capital Maintains Buy on Vincerx Pharma, Lowers Price Target to $3
SVB Securities Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC)
No Data